Adamis Pharmaceuticals
ADMP
#10368
Rank
ยฃ5.38 M
Marketcap
ยฃ0.58
Share price
0.85%
Change (1 day)
-90.54%
Change (1 year)

Revenue for Adamis Pharmaceuticals (ADMP)

Revenue in 2023 (TTM): ยฃ4.31 Million

According to Adamis Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ3.8 Million. In 2022 the company made a revenue of ยฃ4 Million a decrease over the revenue in the year 2021 that were of ยฃ5.71 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamis Pharmaceuticals from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ4.31 M7.57%
2022 ยฃ4 M-29.9%
2021 ยฃ5.71 M-52.83%
2020 ยฃ12.12 M-28.1%
2019 ยฃ16.86 M41.89%
2018 ยฃ11.88 M22.87%
2017 ยฃ9.67 M84.36%
2016 ยฃ5.24 M
2015 N/A
2013 N/A
2012 N/A
2011 N/A-100%
2010 -ยฃ0.04 Million-118.15%
2009 ยฃ0.21 M
2006 ยฃ1.44 M-80.62%
2005 ยฃ7.44 M450.34%
2004 ยฃ1.35 M49.34%
2003 ยฃ0.9 M3.6%
2002 ยฃ0.87 M44.44%
2001 ยฃ0.6 M-43.03%
2000 ยฃ1.06 M56.06%
1999 ยฃ0.68 M61.71%
1998 ยฃ0.42 M-13.56%
1997 ยฃ0.48 M4.24%
1996 ยฃ0.46 M